The long-term trend of the EPS is a vital number as it helps understand the future potential of Acme United Corporation.. It is typically displayed as a percentage and called the EPS growth rate, which is 10.00%. The long-term trend in EPS shows how well the management of Acme United Corporation. is adding value for shareholders.

Acme United Corporation. is in the consumer packaged goods industry and consumer defensive sector. The company CEO is Walter C. Johnsen. Acme United Corp is a supplier of cutting, measuring, first aid and sharpening products to the school, home, office, hardware, sporting goods and industrial markets.

Previous Intraday Performance:

The ACU shares had a previous change of 0.10% which opened at 16.69 and closed at 16.60. It moved to an intraday high of 16.85 and a low of 16.60.

SeekingAlpha:  8 Upcoming Dividend Increases To Start 2019

Historical Performance:

Over the last five trading days, ACU shares returned 3.44% and in the past 30 trading days it returned 19.46%. Over three months, it changed -1.62%. In one year it has changed -29.19% and within that year its 52-week high was 24.98 and its 52-week low was 13.50. ACU stock is 22.94% above its 52 Week Low.

Our calculations result in a 200 day moving average of 19.23 and a 50 day moving average of 15.42. Right now, ACU stock is trading -13.69% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.

SeekingAlpha:  8 Upcoming Dividend Increases To Start 2019


The company has a market cap of $55.9m with 3.4m shares outstanding and a float of 2.4m shares. Trading volume was 331 shares and has experienced an average volume of 8,392 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.


The last annual reported EPS for Acme United Corporation. was 1.09 which ended on 31st of December 2017, which according to the previous close, that is a PE of 15.23. Based on 1 analyst estimate, the estimated EPS for the next quarter is 0.19. The trailing twelve month EPS is 1.27, which comes to a trailing twelve month PE of 13.07. Historically, the PE high was 20.40 and the PE low was 9.70. If the stock reached its PE low, that would represent a price of 12.32, which is a decrease of -25.78%.

Below was the last reported quarterly earnings per share:
09-30-2018:  0.23
06-30-2018:  0.67
03-31-2018:  0.21
12-31-2017:  0.16

The dividend per share is currently 0.48, which is a dividend yield of 2.89%. Also, the payout ratio is 37.80%, therefore the dividend is safe according to our calculations.

Base on our calculations, the intrinsic value per share is 17.09, which means it might be undervalued and has a margin of safety of 2.91%

Indicators Also to Watch:

Based on the latest filings, there is 27.40% of insider ownership and 66.80% of institutional ownership. Short-interest was 49,745, which was 1.48% of shares outstanding. The short-interest ratio or days-to-cover ratio was 3.88. This stock has some short interest, but it might be normal and no need to worry if long the position.

I calculated the beta to be 1.17

PR Newswire:  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bio-Rad Laboratories, Inc. – BIO

Fundamental Numbers:

Based on last reported financials, the company’s return on equity is 6.50%, return on assets is 2.97%, profit margin is 3.77%, price-to-sales is 0.53 and price-to-book is 1.07.

Company Score Card:

Results are out of six:
 3  : Growth Expectations Result
 3  : Financial Safety Result
 1  : Past Performance Result
 4  : Valuation Result
 5  : Dividend Safety Result
 3  : Overall Result

Related Tags: , , ,

Jake McWilliams
I am an independent trader, analyst and algorithmic trading expert, having worked both for the sell side (brokerage) and the buy side (fund administration). I have been trading professionally for about 20 years. I trade stocks and forex and I play both long and short positions in underlying asset or through options. I have experience with discretionary and fully automated systems (Metatrader and Quantshare).


Please enter your comment!
Please enter your name here